These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 7585147)

  • 1. Brain stem activation in spontaneous human migraine attacks.
    Weiller C; May A; Limmroth V; Jüptner M; Kaube H; Schayck RV; Coenen HH; Diener HC
    Nat Med; 1995 Jul; 1(7):658-60. PubMed ID: 7585147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography studies in headache.
    Diener HC
    Headache; 1997; 37(10):622-5. PubMed ID: 9439081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of sumatriptan on cerebral blood flow during migraine headache: measurement by sequential SPECT used 99mTc-ECD background subtraction method].
    Ueda T; Torihara Y; Tsuneyoshi N; Ikeda Y
    No To Shinkei; 2001 Jul; 53(7):625-30. PubMed ID: 11517486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of 5HT in migraine.
    Buzzi MG
    Cephalalgia; 1999 Sep; 19(7):625-6. PubMed ID: 10524654
    [No Abstract]   [Full Text] [Related]  

  • 5. Sumatriptan and cerebral blood flow velocity changes during migraine attacks.
    Totaro R; De Matteis G; Marini C; Baldassarre M; Carolei A
    Headache; 1997; 37(10):635-9. PubMed ID: 9439084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic activation in spontaneous migraine attacks.
    Denuelle M; Fabre N; Payoux P; Chollet F; Geraud G
    Headache; 2007; 47(10):1418-26. PubMed ID: 18052951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging treatments in headache.
    Diener HC; Gendolla A; Jüptner M; Kaube H; Limmroth V
    Eur Neurol; 1997; 38(3):167-74. PubMed ID: 9363828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Positron emission tomographic studies of migraine].
    Géraud G; Denuelle M; Fabre N; Payoux P; Chollet F
    Rev Neurol (Paris); 2005 Jul; 161(6-7):666-70. PubMed ID: 16141953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of serotonin receptors: focus on migraine pathophysiology and treatment.
    Hamel E
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S2-6. PubMed ID: 10563226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients.
    Pinessi L; Rainero I; Savi L; Valfrè W; Limone P; Calvelli P; Del Rizzo P; Gianotti L; Taliano M; Ghigo E; Arvat E
    Cephalalgia; 2000 May; 20(4):223-7. PubMed ID: 10999671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis.
    Sakai Y; Dobson C; Diksic M; Aubé M; Hamel E
    Neurology; 2008 Feb; 70(6):431-9. PubMed ID: 18250288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New aspects of migraine pathophysiology: lessons learned from positron emission tomography.
    Diener HC; May A
    Curr Opin Neurol; 1996 Jun; 9(3):199-201. PubMed ID: 8839610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew.
    Goldstein D
    Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT(1)-like receptor agonists and the pathophysiology of migraine.
    Saxena PR; Ferrari MD
    Trends Pharmacol Sci; 1989 May; 10(5):200-4. PubMed ID: 12722735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sumatriptan: efficacy and contribution to migraine mechanisms.
    Pearce JM
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1103-5. PubMed ID: 1336041
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
    Hoskin KL; Goadsby PJ
    Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.